Back
Cardiff Oncology, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
CRDF
Cardiff Oncology, Inc.
Last Price:
$2.12
Seasonality Move:
11.94%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and CRDF is experiencing selling pressure, which indicates risk of future bearish movement.
Cardiff Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.17 | Sell |
| 20-day SMA: | 2.14 | Sell |
| 50-day SMA: | 2.19 | Sell |
| 200-day SMA: | 2.88 | Sell |
| 8-day EMA: | 2.14 | Sell |
| 20-day EMA: | 2.15 | Sell |
| 50-day EMA: | 2.12 | Sell |
| 200-day EMA: | 1.33 | Buy |
Cardiff Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.26 | Sell |
| Chaikin Money Flow: | -279927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.05 - 2.27) | Sell |
| Bollinger Bands (100): | (1.83 - 2.91) | Sell |
Cardiff Oncology, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiff Oncology, Inc. Stock
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 2.11 while CRDF 8-day simple moving average is 2.17, which is a Sell signal.
-
The stock price of CRDF is 2.11 while Cardiff Oncology, Inc. 20-day SMA is 2.14, which makes it a Sell.
-
Cardiff Oncology, Inc. 50-day simple moving average is 2.19 while CRDF share price is 2.11, making it a Sell technically.
-
CRDF stock price is 2.11 and Cardiff Oncology, Inc. 200-day simple moving average is 2.88, creating a Sell signal.
CRDF Technical Analysis vs Fundamental Analysis
Sell
35
Cardiff Oncology, Inc. (CRDF)
is a Sell
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a SellThe current Cardiff Oncology, Inc. [CRDF] share price is $2.11. The Score for CRDF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Cardiff Oncology, Inc. Stock Info
Market Cap:
142.1M
Price in USD:
2.11
Share Volume:
419.9K
Cardiff Oncology, Inc. 52-Week Range
52-Week High:
5.64
52-Week Low:
1.90
Sell
35
Cardiff Oncology, Inc. (CRDF)
is a Sell
Cardiff Oncology, Inc. Share Price Forecast
-
What is the Cardiff Oncology, Inc. stock price today?The Cardiff Oncology, Inc. stock price is 2.11 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology, Inc. is overvalued.
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 2.11 while CRDF 8-day exponential moving average is 2.14, which is a Sell signal.
-
The stock price of CRDF is 2.11 while Cardiff Oncology, Inc. 20-day EMA is 2.15, which makes it a Sell.
-
Cardiff Oncology, Inc. 50-day exponential moving average is 2.12 while CRDF share price is 2.11, making it a Sell technically.
-
CRDF stock price is 2.11 and Cardiff Oncology, Inc. 200-day simple moving average is 1.33, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology, Inc.
Is Cardiff Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.02 per share.
Technical Analysis of Cardiff Oncology, Inc.
Should I short Cardiff Oncology, Inc. stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cardiff Oncology, Inc. is a Sell
-
Cardiff Oncology, Inc. Relative Strength Index (RSI) is 47.26, which suggest Cardiff Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Cardiff Oncology, Inc. is (2.05 - 2.27), which suggest Cardiff Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Cardiff Oncology, Inc. is (1.83 - 2.91), which suggest Cardiff Oncology, Inc. is a Sell
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.